US Broker Ratings

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 47.89% Potential Upside in the Biotech Sector

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is an intriguing player in the biotechnology sector, particularly for investors seeking exposure to innovative drug discovery solutions. Headquartered in Salt Lake City, Utah, Recursion..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: A 55% Potential Upside Amid Promising Biotech Developments

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a key player in the biotechnology sector, is capturing investor attention with a compelling potential upside of 55.11%. With its innovative focus on cellular metabolism..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 70.5% Potential Upside Amidst Healthcare Market Dynamics

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector, particularly within the medical devices industry, has captured investor interest with its notable potential upside of 70.5%. This San..

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Exploring a 61.72% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector, particularly in the medical devices industry, is capturing investor attention with its innovative approach to diabetes management...

Phreesia, Inc. (PHR) Stock Analysis: 17% Upside Potential and Robust Revenue Growth

Phreesia, Inc. (NYSE: PHR), a healthcare sector innovator specializing in health information services, is capturing investor attention with its promising growth metrics and positive analyst sentiment. With a market capitalization..

PACS Group, Inc. (PACS) Stock Analysis: A 139% Potential Upside Sparks Investor Interest

PACS Group, Inc. (PACS) is stirring up excitement among investors with its promising potential upside of 139.22%. Operating in the burgeoning healthcare sector, specifically within medical care facilities, PACS is..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 165.75% Potential Upside in Regenerative Medicine

Investors with an affinity for high-stakes opportunities in the healthcare sector might find Mesoblast Limited (MESO) an intriguing prospect. A biotechnology company based in Australia, Mesoblast specializes in the development..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unveiling a 136% Upside Potential in Rare Disease Therapies

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company at the forefront of developing treatments for rare kidney and metabolic diseases, presents an intriguing investment proposition with a potential upside of..

Belite Bio, Inc (BLTE) Stock Analysis: High Potential Upside in Retinal Therapeutics

Belite Bio, Inc (BLTE), a promising player in the biotechnology industry, has been capturing the attention of investors with its focus on novel therapeutics for retinal degenerative eye diseases. With..

Disc Medicine, Inc. (IRON) Stock Analysis: High Potential with a 90% Upside Amid Robust Buy Ratings

For investors seeking exposure to the cutting-edge realm of biotechnology, Disc Medicine, Inc. (NASDAQ: IRON) presents an intriguing opportunity. Specializing in the development of novel treatments for serious hematologic conditions,..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Exploring a 68% Upside with Strong Buy Ratings

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the medical devices industry, is capturing attention with its potential for significant upside. With a market capitalization of $1.59 billion, Alphatec..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: 34.51% Potential Upside Sparks Investor Interest

Guardian Pharmacy Services, Inc. (GRDN), a key player in the healthcare sector, specializes in providing pharmacy services to long-term care facilities (LTCFs) across the United States. With its headquarters in..

Concentra Group Holdings Parent (CON): Investor Outlook Reveals 33% Upside Potential

For investors seeking opportunities in the healthcare sector, Concentra Group Holdings Parent (NASDAQ: CON) presents a compelling case. With a market capitalization of $2.69 billion, this U.S.-based company is a..

HUTCHMED (China) Limited (HCM) Stock Analysis: A Healthcare Innovator with a 65.79% Potential Upside

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector, is making waves in the drug manufacturing industry with its promising therapeutics and significant growth potential. The company’s..

UFP Technologies, Inc. (UFPT) Investor Outlook: Assessing a 33.4% Potential Upside in the Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.8 billion, this Newburyport, Massachusetts-based company is..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: Exploring a 127% Potential Upside

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning player in the biotechnology sector, presents a compelling investment opportunity amid its pioneering approach to treating inflammatory and immunology conditions. With a market..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Unlocking a 21.91% Upside Potential

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is a noteworthy player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Based in Rockville, Maryland, Supernus focuses on developing..

Twist Bioscience Corporation (TWST) Investor Outlook: Exploring a Potential 37% Upside in the Healthcare Sector

Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the healthcare sector specializing in diagnostics and research, has been drawing significant attention from investors due to its innovative approach to..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Sector with a 6.09% Upside Potential

Galapagos NV (NASDAQ: GLPG), a prominent player in the biotechnology sector, is capturing investor attention with its strategic focus on developing innovative therapies in oncology and immunology. Headquartered in Mechelen,..

LifeStance Health Group, Inc. (LFST) Stock Analysis: A 78.57% Potential Upside in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the healthcare sector, specifically within the medical care facilities industry, has captured investor attention with its significant potential upside of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds